Loading company…
Oncovalent Therapeutics develops small molecule oncology therapeutics.
Oncovalent Therapeutics is an early-stage company focused on small molecule oncology therapeutics. Founded in 2015 and based in California, US, it changed its name from SUMO Bioscience, Inc. in 2020.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in